LAZARD ASSET MANAGEMENT LLC - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$133
+87.3%
11,022
+93.4%
0.00%
Q2 2023$71
-58.2%
5,700
-62.9%
0.00%
Q1 2023$170
-1.7%
15,380
+8.4%
0.00%
Q4 2022$173
-99.8%
14,193
+44.3%
0.00%
Q3 2022$102,000
-2.9%
9,8370.0%0.00%
Q2 2022$105,000
+90.9%
9,837
+68.0%
0.00%
Q1 2022$55,000
-17.9%
5,8560.0%0.00%
Q4 2021$67,000
-94.1%
5,856
-95.1%
0.00%
-100.0%
Q3 2021$1,130,000
+1954.5%
118,415
+1993.2%
0.00%
Q1 2021$55,000
-16.7%
5,657
+95.5%
0.00%
Q4 2020$66,000
+65.0%
2,8940.0%0.00%
Q3 2020$40,000
-43.7%
2,894
-38.8%
0.00%
Q2 2020$71,000
-2.7%
4,727
-40.8%
0.00%
Q1 2020$73,000
+108.6%
7,986
+118.9%
0.00%
Q4 2019$35,000
+400.0%
3,648
+301.3%
0.00%
Q3 2019$7,000
-91.7%
909
-85.4%
0.00%
Q1 2019$84,000
-42.5%
6,243
-59.3%
0.00%
Q4 2018$146,000
-88.6%
15,323
-83.0%
0.00%
-100.0%
Q2 2015$1,278,00090,3550.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,524,022$127,972,10812.11%
Perceptive Advisors 27,692,917$336,745,87011.23%
Redmile Group, LLC 16,944,621$206,046,5919.80%
Finepoint Capital LP 1,489,025$18,106,5449.02%
CM Management, LLC 450,000$5,472,0005.81%
Avoro Capital Advisors LLC 27,400,000$333,184,0005.20%
MPM BioImpact LLC 716,139$8,708,2502.32%
Artal Group S.A. 4,062,567$49,4012.12%
SECTORAL ASSET MANAGEMENT INC 803,464$9,770,1221.90%
GREAT POINT PARTNERS LLC 857,000$10,421,1201.90%
View complete list of AMICUS THERAPEUTICS INC shareholders